Primary congenital glaucoma

Primary Congenital Glaucoma

Primary Congenital Glaucoma (PCG) is a rare genetic eye disorder that affects infants and young children. It is characterized by an abnormal development of the eye's drainage system, leading to increased intraocular pressure (IOP), which can damage the optic nerve and result in vision loss.

Etiology

PCG is primarily caused by developmental anomalies in the trabecular meshwork and anterior chamber angle of the eye. These anomalies impede the normal outflow of aqueous humor, leading to elevated IOP. The condition is often inherited in an autosomal recessive pattern, with mutations in the CYP1B1 gene being the most common genetic cause.

Clinical Presentation

Infants with PCG typically present with the classic triad of symptoms:

• Epiphora (excessive tearing)
• Photophobia (sensitivity to light)
• Blepharospasm (involuntary tight closure of the eyelids)

Other signs include corneal enlargement (buphthalmos), corneal clouding, and increased corneal diameter.

Diagnosis

Diagnosis of PCG is based on clinical examination and measurement of IOP. Gonioscopy can be used to assess the angle of the anterior chamber. Genetic testing may be performed to identify mutations in the CYP1B1 gene or other associated genes.

Treatment

The primary treatment for PCG is surgical intervention to reduce IOP and prevent optic nerve damage. Common surgical procedures include:

• Goniotomy: An incision is made in the trabecular meshwork to improve aqueous outflow.
• Trabeculotomy: A surgical opening is created in the trabecular meshwork and Schlemm's canal.
• Trabeculectomy: A filtration surgery to create a new drainage pathway for aqueous humor.

Medications such as beta-blockers or carbonic anhydrase inhibitors may be used as adjunctive therapy to control IOP.

Prognosis

The prognosis for PCG varies depending on the severity of the condition and the success of surgical interventions. Early diagnosis and treatment are crucial for preserving vision. Regular follow-up is necessary to monitor IOP and assess for any complications.

Epidemiology

PCG is a rare condition, with an estimated incidence of 1 in 10,000 to 1 in 20,000 live births. It is more prevalent in certain populations, such as the Romani people and in regions with high rates of consanguinity.

Research and Future Directions

Ongoing research aims to better understand the genetic basis of PCG and to develop novel therapeutic approaches. Gene therapy and advanced surgical techniques are areas of active investigation.

See Also

• Glaucoma
• CYP1B1
• Trabecular meshwork

External Links

• Glaucoma Research Foundation
• National Organization for Rare Disorders

NIH genetic and rare disease info

• NIH info on Primary congenital glaucoma

Primary congenital glaucoma is a rare disease.